Copan Diagnostics is pleased to announce that its innovative urine collection and transport device, UriSponge®, has received clearance from the U.S. Food and Drug Administration (FDA).

December 9, 2024

WASPLAB® AND PHENOMATRIX® AI ARE MAKING WAVES IN CANADA

February 22, 2024

Copan Colibrí™ Receives Third FDA Clearance, Further Expanding Automated ID/AST Workup Capabilities

January 30, 2024

Copan Unveils Website Redesign

January 22, 2024

Copan Diagnostics Announces Leadership Change

February 2, 2023

You are leaving the COPAN Diagnostics U.S. website

You are about to visit a global COPAN group website Content available on that site may include information on products or applications that may not be available, cleared, approved, or applicable in all countries. Always refer to the applicable product labeling and Instructions for Use for the product available in your country or region..